Samuel Gershon: Ketamine, the "new" breakthrough in the trestment of depression
Samuel Gershon’s reply to Bruno Müller-Oerlinghausen’s comment
Thank you, Bruno, for your comments on my report on ketamines. You emphasize the concerns regarding their hallucinogenic and delirious effects which we found to occur in many of our study patients. Several other groups have reported longer term follow ups than we did and a disturbed mental state was seen for some days. In addition, I wish to mention that their other claim as a treatment for depression requires clarification, especially as some of the data on this claim was reported from uncontrolled usage in a NY clinic where there is some question also as to the specificity of the depressive diagnosis.
February 25, 2021